2024-03-29T01:21:41Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_630A38C698EC
2024-03-23T02:27:04Z
serval:BIB_630A38C698EC
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma.
10.1038/s43018-021-00221-9
000675007800001
35121945
Haas
L.
author
Elewaut
A.
author
Gerard
C.L.
author
Umkehrer
C.
author
Leiendecker
L.
author
Pedersen
M.
author
Krecioch
I.
author
Hoffmann
D.
author
Novatchkova
M.
author
Kuttke
M.
author
Neumann
T.
author
da Silva
I.P.
author
Witthock
H.
author
Cuendet
M.A.
author
Carotta
S.
author
Harrington
K.J.
author
Zuber
J.
author
Scolyer
R.A.
author
Long
G.V.
author
Wilmott
J.S.
author
Michielin
O.
author
Vanharanta
S.
author
Wiesner
T.
author
Obenauf
A.C.
author
article
2021-07
Nature cancer
2662-1347
2662-1347
journal
2
7
693-708
Cancer Research
Oncology
eng
60_published
peer-reviewed
Publication types: Journal Article
Publication Status: ppublish